REVISION THERAPEUTICS Trademark

Trademark Overview

On Friday, November 16, 2018, a trademark application was filed for REVISION THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the REVISION THERAPEUTICS trademark a serial number of 88196727. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 25, 2022. This trademark is owned by ReVision Therapeutics, Inc.. The REVISION THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for the treatment of dry eye and retinal diseases; medicated and non-medicated eye drops; pharmaceutical preparations, serums and injectables for the treatment of retinal disease
revision therapeutics

General Information

Serial Number88196727
Word MarkREVISION THERAPEUTICS
Filing DateFriday, November 16, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 25, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 23, 2019

Trademark Statements

Goods and ServicesPharmaceuticals for the treatment of dry eye and retinal diseases; medicated and non-medicated eye drops; pharmaceutical preparations, serums and injectables for the treatment of retinal disease
Disclaimer with Predetermined Text"THERAPEUTICS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 4, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameReVision Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWilimington, DE 19808
Party NameReVision Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWilimington, DE 19808

Trademark Events

Event DateEvent Description
Monday, July 25, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 25, 2022ABANDONMENT - NO USE STATEMENT FILED
Thursday, December 30, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 29, 2021SOU EXTENSION 5 GRANTED
Monday, December 20, 2021SOU EXTENSION 5 FILED
Wednesday, December 29, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, December 20, 2021TEAS EXTENSION RECEIVED
Friday, June 18, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 16, 2021SOU EXTENSION 4 GRANTED
Wednesday, June 16, 2021SOU EXTENSION 4 FILED
Wednesday, June 16, 2021TEAS EXTENSION RECEIVED
Tuesday, December 22, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 18, 2020SOU EXTENSION 3 GRANTED
Friday, December 18, 2020SOU EXTENSION 3 FILED
Friday, December 18, 2020TEAS EXTENSION RECEIVED
Friday, June 19, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 17, 2020SOU EXTENSION 2 GRANTED
Wednesday, June 17, 2020SOU EXTENSION 2 FILED
Wednesday, June 17, 2020TEAS EXTENSION RECEIVED
Thursday, December 5, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 3, 2019SOU EXTENSION 1 GRANTED
Tuesday, December 3, 2019SOU EXTENSION 1 FILED
Tuesday, December 3, 2019TEAS EXTENSION RECEIVED
Tuesday, June 18, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 23, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 23, 2019PUBLISHED FOR OPPOSITION
Wednesday, April 3, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 19, 2019LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, March 18, 2019ASSIGNED TO LIE
Tuesday, February 26, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 26, 2019EXAMINER'S AMENDMENT ENTERED
Tuesday, February 26, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, February 26, 2019EXAMINERS AMENDMENT E-MAILED
Tuesday, February 26, 2019EXAMINERS AMENDMENT -WRITTEN
Thursday, February 21, 2019ASSIGNED TO EXAMINER
Tuesday, December 4, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 20, 2018NEW APPLICATION ENTERED

Related Keywords

therapeutics revision medicated retinal treatment serums injectables disease preparations drops diseases pharmaceuticals